Patent · US Active

Factor IX fusion proteins and methods of making and using same

US10745680B2 · kind B2 · utility

3Cited by
217References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 3, 2016
Grant dateAug 18, 2020
Priority date
Expiry dateApr 8, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides Factor IX (FIX) fusion proteins comprising at least one heterologous moiety, such as an XTEN. The present invention further discloses methods of making and using the FIX fusion proteins.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.